An offer to buy Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials ... Read More
After what he calls a “soft” first quarter, Leede Jones Gable analyst Doug Loe has maint... Read More
Following the company’s third quarter results, Leede Jones Gable analyst Douglas Loe remains b... Read More
Softer than expected quarterly revenue and more muted guidance from management are reasons to pare b... Read More
The share price for drug company Theratechnologies (Theratechnologies Stock Quote, Charts, News, Ana... Read More
The stock has fallen on hard times over the past couple of years, but investors should be seeing bet... Read More
Research Capital analyst André Uddin delivered an update to clients on Friday on HIV-specializing T... Read More
It’s been steady as it goes for Montreal-based endocrinology and oncology drug developer Theratech... Read More
New quarterly results from Canadian drug developer Theratechnologies (Theratechnologies Stock Quote,... Read More
André Uddin from Research Capital Corporation thinks Theratechnologies (Theratechnologies Stock Quo... Read More
André Uddin from Research Capital Corporation is slightly more tentative on Canadian biotech name ... Read More
It seems fair to say that biotech hasn’t been the hottest of fields for much of this year. Money c... Read More
André Uddin from Research Capital Corporation is still tight with Theratechnologies (Theratechnolog... Read More
With its second quarter now in the books, André Uddin from Research Capital Corporation has maintai... Read More
Calling the company’s pipeline underappreciated, Mackie Research analyst André Uddin raised his t... Read More
Specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH) misse... Read More
On the basis of extended timelines for clinical testing, Echelon Wealth Partners analyst Douglas Loe... Read More
Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologie... Read More
Share
Tweet
pin
Share